Leveraging our excellent medical and academic expertise, we are committed to supporting clients with the development of drugs targeting allergy and respiratory diseases and to conducting patient-oriented research that helps people suffering from these conditions.
We are a highly specialized, academia-affiliated research unit for early-phase and proof-of-concept clinical trials in the Clinical Research Center Hannover. Our focus is on airway diseases such as asthma, allergic rhinitis, COPD, and interstitial lung diseases, in particular idiopathic pulmonary fibrosis.
We conduct trials with our highly qualified and dedicated team of physicians, study nurses, project managers, and medical documentation specialists, accompanied by an independent quality assurance unit. We offer a broad range of challenge models for our studies. With our strong academic background we support our clients in finding the proof-of concept model and study design best suited to their particular requirements.